Extensively drug-resistant tuberculosis in South Korea: Risk factors and treatment outcomes among patients at a tertiary referral hospital

Christie Y. Jeon, Hee Hwang Soo, Hong Min Jin, D. Rebecca Prevots, Lisa C. Goldfeder, Hyeyoung Lee, Yong Eum Seok, Soo Jeon Doo, Seok Kang Hyung, Hee Kim Jin, Ju Kim Byoung, Yeon Kim Dae, Steven M. Holland, Kyu Park Seung, Nae Cho Sang, Clifton E. Barry, Laura E. Via

Research output: Contribution to journalArticlepeer-review

98 Citations (Scopus)


Background. Extensively drug-resistant (XDR) tuberculosis (TB) is a major public health threat in South Korea. Methods. We analyzed baseline epidemiological data for 250 patients enrolled in an ongoing prospective observational study of TB at a large tertiary referral hospital in South Korea. Results. Twenty-six subjects with XDR TB were identified; all were patients who had previously received TB therapy. Cumulative previous treatment duration (range, 18-34 months; odds ratio [OR], 5.6; 95% confidence interval [CI], 1.0-59), number of previously received second-line anti-TB drugs (OR, 1.3; 95% CI, 1.1-1.5), and female sex (OR, 3.2; 95% CI, 1.1-8.3) were significantly associated with XDR TB in crude analyses. After controlling for other factors in a multivariable model, cumulative previous treatment duration remained significantly associated with XDR TB (OR, 5.8; 95% CI, 1.0-61). Subjects with XDR TB were more likely to produce culture-positive sputum at 6 months, compared with patients with non-multidrug resistant TB (risk ratio, 13; 95% CI, 5.1-53). Kanamycin resistance was found to be predictive of 6-month culture positivity after adjustment for ofloxacin and streptomycin resistance (risk ratio, 3.9; 95% CI, 1.9-11). Conclusions. XDR TB was found to be associated with the cumulative duration of previous treatment with second-line TB drugs among subjects in a tertiary care TB hospital. Patients with XDR TB were more likely to not respond to therapy, and successful conversion of sputum culture results to negative was correlated with initial susceptibility to both fluoroquinolones and kanamycin but not to streptomycin.

Original languageEnglish
Pages (from-to)42-49
Number of pages8
JournalClinical Infectious Diseases
Issue number1
Publication statusPublished - 2008 Jan 1

Bibliographical note

Funding Information:
Financial support. The Intramural Research Program and the Office of Global Research of the National Institutes of Allergy and Infectious Diseases, National Institutes of Health; and the Korean Ministry of Health and Welfare, through the Korean Institute of Tuberculosis and the Korean National Tuberculosis Association. Potential conflicts of interest. All authors: no conflicts.

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)
  • Infectious Diseases


Dive into the research topics of 'Extensively drug-resistant tuberculosis in South Korea: Risk factors and treatment outcomes among patients at a tertiary referral hospital'. Together they form a unique fingerprint.

Cite this